11/25/2014 | CVIG | S&P changes WellPoint to positive
|
10/29/2014 | CV | Market Commentary: Convertibles little changed ahead of the Fed; American Realty drops; Synergy prices deal
|
9/23/2014 | CV | Market Commentary: Morning Commentary: Planned Tesaro looks rich on the mids; Salix active amid more M&A chatter
|
9/12/2014 | IGLM | WellPoint completes Sept. 11 redemption of all 5.25% notes due 2016
|
9/11/2014 | PP | Market Commentary: Twitter’s $1.3 billion offering around issue in gray market; WellPoint drops; Tesla slips
|
9/11/2014 | CV | Market Commentary: Twitter’s $1.3 billion offering around issue in gray market; WellPoint drops; Tesla slips
|
8/8/2014 | EMHYMUPFPV | Market Commentary: Primary quiets following deal rush; Citi mixed; Synchrony tightens; Tyson active
|
8/8/2014 | IG | Market Commentary: Primary quiets following deal rush; Citi mixed; Synchrony tightens; Tyson active
|
8/8/2014 | IG | New Issue: WellPoint prices $2.7 billion senior notes due 2019, 2024, 2044, 2054
|
8/7/2014 | EMHYMUPFPV | Market Commentary: Packed primary session sees Citigroup, CVS, Berkshire Hathaway price; bond spreads ease
|
8/7/2014 | IG | Market Commentary: Packed primary session sees Citigroup, CVS, Berkshire Hathaway price; bond spreads ease
|
8/7/2014 | CVIG | Moody’s rates WellPoint debt Baa2
|
8/7/2014 | CVIG | S&P gives A- to WellPoint debt
|
8/7/2014 | CVIG | Fitch rates WellPoint notes BBB
|
8/7/2014 | IG | Market Commentary: Morning Commentary: High-grade bond spreads steady ahead of supply; bank paper flat to softer
|
8/7/2014 | IG | WellPoint set to offer senior notes in four maturities
|
8/5/2014 | CVIG | Fitch drops WellPoint notes to BBB
|
7/29/2014 | PP | Market Commentary: WellPoint debt drifts down ahead of earnings; Herbalife convertibles, stock decline
|
7/29/2014 | CV | Market Commentary: WellPoint debt drifts down ahead of earnings; Herbalife convertibles, stock decline
|
7/7/2014 | PP | Market Commentary: Convertibles generally quiet; Macquarie Infrastructure on tap; Chinese internet paper eyed
|
7/7/2014 | CV | Market Commentary: Convertibles generally quiet; Macquarie Infrastructure on tap; Chinese internet paper eyed
|
7/7/2014 | CV | Market Commentary: Morning Commentary: Intel, WellPoint dominate thin post-holiday trading; Micron 3% in focus
|
7/3/2014 | PP | Market Commentary: NQ Mobile unmoved despite stock plunge; pre-holiday market quiet ahead of early close
|
7/3/2014 | CV | Market Commentary: NQ Mobile unmoved despite stock plunge; pre-holiday market quiet ahead of early close
|
5/13/2014 | CV | Market Commentary: L-3 down in huge volume on call news; Dealertrack swoons outright; Spirit Realty to price
|
4/17/2014 | CV | Market Commentary: Midday Commentary: Convertibles volume low; SanDisk rallies; WellPoint slips
|
4/16/2014 | CV | Market Commentary: Midday Commentary: WellPoint bonds active; Tesla rises in midday trading
|
4/16/2014 | CV | Market Commentary: Convertibles quiet as Street thins; WellPoint 'traded a lot'; Tesla Motors bonds climb
|
4/15/2014 | CV | Market Commentary: Convertibles quiet, volume light; WellPoint paper active; Goodrich Petroleum flat
|
4/10/2014 | CV | Market Commentary: Convertibles mostly steady, some vol. names up as equities slide; WellPoint flat; AMAG slips
|
4/10/2014 | CV | Market Commentary: Midday commentary: WellPoint flat in active trade; Priceline lower with shares
|
4/9/2014 | CV | Market Commentary: Midday Commentary: Convertibles mostly quiet; WellPoint trades higher in active trade
|
4/9/2014 | CV | Market Commentary: WellPoint flat to higher in active trade; larger, higher-grade issues trade; RPM in focus
|
3/24/2014 | CV | Market Commentary: Midday Commentary: WellPoint's long bonds rise in early trade; Tesla flat on weaker shares
|
2/11/2014 | CV | Market Commentary: Planned AMAG looks cheap; Canadian Solar launches; WebMD slips outright, adds on hedge
|
2/7/2014 | CV | Market Commentary: New PDL BioPharma trades up outright, mixed on hedge; existing PDL up with exchange offer
|
1/29/2014 | CV | Market Commentary: Midday Commentary: Fluidigm launches $175 million convertible; WellPoint lower after earnings
|
1/29/2014 | CV | Market Commentary: Fluidigm talk tightened; Medivation jumps on positive trial data; Illumina trades in line
|
1/28/2014 | CV | Market Commentary: WellPoint slips in line with shares; AK Steel surges after earnings beat; Regis moves up
|
8/13/2013 | IGLM | WellPoint wraps tenders for $700 million first-, second-tranche notes
|
7/30/2013 | CVIG | S&P gives WellPoint debt A-
|
7/30/2013 | CVIG | Fitch to rate WellPoint notes BBB+
|
7/30/2013 | IG | New Issue: WellPoint sells $1.25 billion senior notes due 2018, 2044
|
7/30/2013 | IG | Market Commentary: Huntington, WellPoint price; high-grade bonds a 'touch' tighter, Halliburton long bonds firm
|
7/30/2013 | IG | WellPoint eyes two-part offering of notes due 2018, 2044 for Tuesday
|
7/30/2013 | CVIG | Moody's: WellPoint notes Baa2
|
7/30/2013 | IGLM | WellPoint tenders for $600 million first- and second-tranche notes
|
7/22/2013 | CV | Market Commentary: Convertibles mostly quiet as traders eye upcoming earnings; older Jakks extends losses
|
7/5/2013 | CV | Market Commentary: Convertibles quiet after holiday; 'soft' market eyed after job report pushes rates higher
|
2/13/2013 | CV | Market Commentary: BlackRock Kelso flat; planned Cliffs wrestles borrow; Starwood up; WellPoint flat to lower
|
10/17/2012 | CV | Market Commentary: Intel flat to lower outright, up on hedge; Knight firm; Stillwater, WellPoint doing well
|
10/9/2012 | CV | WellPoint greenshoe exercised, lifting convertibles to $1.5 billion
|
10/5/2012 | CV | Market Commentary: Convertibles mostly quiet; WellPoint puts in notably strong week; Home Inns drops on swap
|
10/4/2012 | CV | Market Commentary: New Ares Capital flat after pricing at discount; WellPoint gains; NuVasive loses on hedge
|
10/3/2012 | CV | Market Commentary: New WellPoint up on debut; Ares Capital on tap; existing Ares paper quiet; NuVasive drops
|
10/2/2012 | BKIG | Fitch rates WellPoint notes BBB+
|
10/2/2012 | CV | New Issue: WellPoint prices $1.35 billion 30-year convertible debentures to yield 2.75%, up 25%
|
10/2/2012 | CV | Market Commentary: WellPoint adds in the gray, models attractively; Molina, Amerigroup quiet; Illumina eyed
|
10/2/2012 | CVIG | S&P: WellPoint notes A
|
10/1/2012 | CV | Market Commentary: Lam Research trades actively; Molson Coors 'in' slightly; WellPoint offers $1.35 billion
|
10/1/2012 | CV | WellPoint plans $1.35 billion 30-year convertible debentures to yield 2.5%-3%, up 20%-25%
|
9/5/2012 | IG | Market Commentary: Wellpoint, Berkshire, EOG, Principal among huge slate of deals; Waste Management notes firm
|
9/5/2012 | IG | New Issue: Wellpoint sells $3.25 billion of notes in four tranches for Amerigroup acquisition
|
9/5/2012 | IG | Fitch lowers WellPoint
|
9/5/2012 | IG | Moody's rates WellPoint debt Baa2
|
7/9/2012 | IG | S&P cuts WellPoint to stable
|
7/9/2012 | IG | Fitch might lower WellPoint
|
7/9/2012 | BKIG | WellPoint plans to raise $4.2 billion to fund Amerigroup purchase
|
7/9/2012 | HY | Moody's could lift Amerigroup
|
7/9/2012 | HY | S&P places Amerigroup on positive watch
|
7/9/2012 | IG | Moody's lowers WellPoint
|
5/3/2012 | IG | Market Commentary: U.S. Bancorp, ABB Finance sell paper as primary volume wanes; bank paper, WellPoint widen
|
5/2/2012 | IG | Market Commentary: GSK does massive trade alongside BP, WellPoint, Ericsson, Barclays; Ericsson comes in 15 bps
|
5/2/2012 | IG | New Issue: WellPoint sells $1.75 billion of notes due 2022, 2042
|
5/2/2012 | IG | S&P rates WellPoint notes A-
|
5/2/2012 | IG | Moody's: WellPoint debt Baa1
|
4/2/2012 | IG | S&P ups WellPoint to positive
|
2/29/2012 | IG | Moody's affirms WellPoint
|
1/9/2012 | IG | Fitch affirms WellPoint
|
12/9/2011 | CVIGPF | WellPoint files automatic shelf for debt, preferreds and stock
|
8/10/2011 | IG | S&P rates WellPoint notes A-
|
8/10/2011 | IG | Moody's: WellPoint debt Baa1
|
8/10/2011 | IG | Fitch rates WellPoint notes A-
|
8/10/2011 | IG | Market Commentary: High-grade issuers flood primary on low yields as cash-rich investors buy; bonds edge up
|
8/10/2011 | IG | New Issue: WellPoint taps market for $1.1 billion of notes in two tranches
|
3/28/2011 | IG | S&P: WellPoint view to stable
|
3/8/2011 | SP | New Issue: Goldman Sachs prices $22.5 million 6% equity-linked notes on WellPoint
|
1/12/2011 | IG | Fitch affirms health insurers; outlooks up to stable
|
12/10/2010 | IG | Moody's: WellPoint view stable
|
8/9/2010 | IG | New Issue: WellPoint sells upsized $1 billion of notes in 10-, 30-year tranches
|
8/9/2010 | IG | S&P rates WellPoint notes A-
|
8/9/2010 | IG | Moody's gives WellPoint issue Baa1
|
8/9/2010 | IG | Fitch rates WellPoint notes A-
|
8/9/2010 | IG | Market Commentary: NuStar, Anadarko, WellPoint, Toyota, Simon Property price in high grade; notes firm in trading
|
5/11/2010 | IG | Fitch affirms WellPoint
|
5/11/2010 | IG | S&P affirms WellPoint
|
10/5/2009 | IG | Moody's affirms WellPoint
|
9/23/2009 | IG | S&P affirms WellPoint
|
9/18/2009 | IG | Market Commentary: National Life Insurance, Zions Bank price bonds; Citigroup, Barclays, Markel trade tighter
|
7/27/2009 | SS | Market Commentary: Agilent to buy Varian in all-cash deal; Aetna sale rumors surface; El Paso secures partner
|
7/24/2009 | IG | Fitch: Outlook negative for health insurers
|
6/5/2009 | IG | New Issue: Express Scripts releases terms for $2.5 billion notes in three-, five-, 10-year tranches
|
6/4/2009 | IG | New Issue: Express Scripts sells upsized $2.5 billion three-, five-, 10-year notes
|
6/4/2009 | IG | Market Commentary: Express Scripts, Pricoa, PNC, Harris, Bunge, Yara offer bonds; Harris trades well, BofA eases
|
4/13/2009 | SS | Market Commentary: Express Scripts up on WellPoint buyout offer; CF gains RiskMetrics vote; Agrium pushes ahead
|
4/13/2009 | IG | Moody's affirms WellPoint
|
4/13/2009 | IG | Fitch: WellPoint unchanged
|
2/3/2009 | IG | S&P gives WellPoint notes A-
|
2/3/2009 | IG | Market Commentary: Altria Group, P&G, Sunoco, Harley-Davidson, KfW sell bonds, Novartis plans issue
|
2/2/2009 | IG | Fitch gives WellPoint notes A-
|
2/2/2009 | IG | Market Commentary: WellPoint, Asian Development Bank sell bonds; foreign banks on tap; Hess, ConocoPhillips strengthen
|
2/2/2009 | IG | New Issue: WellPoint prices $1 billion notes in five-, 10-year tranches
|
2/2/2009 | IG | Moody's rates WellPoint notes Baa1
|
1/30/2009 | IG | Moody's: WellPoint outlook negative
|
12/23/2008 | IG | S&P assigns WellPoint notes A-
|
12/12/2008 | CVIG | WellPoint files automatic shelf registration
|
11/21/2008 | IG | S&P affirms WellPoint
|
11/20/2008 | IG | S&P affirms WellPoint
|
5/19/2008 | IG | Fitch affirms WellPoint
|
4/24/2008 | IG | S&P: WellPoint outlook negative
|
3/11/2008 | IG | S&P affirms WellPoint
|
2/22/2008 | SS | Market Commentary: CHC up 40% on buyout news; shareholders eye Feb. 29 deadline for UnitedHealth-Sierra merger
|
2/14/2008 | SS | Market Commentary: Analyst sees no clarity on Clear Channel deal; airline merger buzz fails to halt skidding share prices
|
11/20/2007 | IG | S&P ups WellPoint
|
2/26/2007 | CV | S&P: No change for WellPoint
|
5/24/2006 | CV | S&P boosts WellPoint outlook to positive
|
1/6/2006 | CV | S&P gives WellPoint notes BBB+
|
1/6/2006 | CV | Fitch assigns WellPoint notes A-
|
12/30/2005 | CV | WellPoint files debt, stock shelf
|
12/7/2005 | CV | New Issue: Morgan Stanley prices $31.52 million 20% Perqs exchangeable for WellPoint
|